印度的CDSCO标明50多种药物"不符合标准质量", Indian CDSCO flags over 50 drugs as "not of standard quality", raising concerns about counterfeit medications.

印度政府的CDSCO将50多种药物标为“非标准质量”, The Indian government's CDSCO has flagged over 50 drugs as "not of standard quality," raising concerns about counterfeit medications among consumers. 包括Sun Pharma和Glennmark在内的主要制药公司否认责任,声称这些药物是虚假的。 Major pharmaceutical companies, including Sun Pharma and Glenmark, deny responsibility, asserting that these drugs are spurious. 虽然印度药品联盟声称,这些NSQ药物构成的风险微不足道,但印度药品联盟强调,必须区分NSQ和假药,以保护该行业的声誉和公共健康。 While the CDSCO claims these NSQ drugs pose negligible risks, the Indian Pharmaceutical Alliance stresses the need to distinguish between NSQ and counterfeit drugs to protect the industry's reputation and public health.